TNFRSF12A and cancer: Its cognate receptor Fn14 was initially described as an immediate-early response gene in the mouse fibroblast line NIH3T3 [22] and was later reported to be significantly upregulated in a variety of conditions associated with inflammatory tissue remodelling, repair, and cancer, making it a promising therapeutic target [23,24].